Overview

Brexpiprazole in Patients With Acute Schizophrenia

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of brexpiprazole for the treatment of adults experiencing an acute episode of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Brexpiprazole
Quetiapine Fumarate